Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial

The Lancet Neurology

Volumn 9, Issue 5, 2010, Pages 489-497

  Wong, Ka Sing Lawrence ^a   Chen, Christopher ^b   Fu, Jianhui ^c   Chang, Hui Meng ^d   Suwanwela, Nijasri C ^e   Huang, Yining N ^f   Han, Zhao ^g   Tan, Kay Sin ^h   Ratanakorn, Disya ⁱ   Chollate, Pavithra ^j   Zhao, Yudong ^j   Koh, Angeline ^j   Hao, Qing ^a   Markus, Hugh S ^k  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c FUDAN UNIVERSITY   (China)

^d SINGAPORE GENERAL HOSPITAL   (Singapore)

^e KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^f PEKING UNIVERSITY FIRST HOSPITAL   (China)

^g WENZHOU MEDICAL UNIVERSITY   (China)

^h UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

ⁱ MAHIDOL UNIVERSITY   (Thailand)

^j SINGAPORE CLINICAL RESEARCH INSTITUTE   (Singapore)

^k ST GEORGE S HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; AGED; ARTICLE; CAROTID ARTERY OBSTRUCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; INTERNAL CAROTID ARTERY; MAJOR CLINICAL STUDY; MALE; MICROEMBOLISM; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SINGLE BLIND PROCEDURE; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 77950627212     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70060-0     Document Type: Article

References (30)

1. Gorelick P.B., Wong K.S., Bae H.J., and Pandey D.K. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke 39 (2008) 2396-2399
2. Wong L.K. Global burden of intracranial atherosclerosis. Int J Stroke 1 (2006) 158-159
3. Rothwell P.M., Buchan A., and Johnston S.C. Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol 5 (2006) 323-331
4. Lovett J.K., Coull A.J., and Rothwell P.M. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 62 (2004) 569-573
5. Gulli G., Khan S., and Markus H.S. Vertebrobasilar stenosis predicts high early recurrent stroke risk in posterior circulation stroke and TIA. Stroke 40 (2009) 2732-2737
6. Marquardt L., Kuker W., Chandratheva A., Geraghty O., and Rothwell P.M. Incidence and prognosis of ≥50% symptomatic vertebral or basilar artery stenosis: prospective population-based study. Brain 132 (2009) 982-988
7. Ovbiagele B., Cruz-Flores S., Lynn M.J., and Chimowitz M.I. Early stroke risk after transient ischemic attack among individuals with symptomatic intracranial artery stenosis. Arch Neurol 65 (2008) 733-737
8. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., and Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
9. Diener H.C., Bogousslavsky J., Brass L.M., et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364 (2004) 331-337
10. Markus H.S., Droste D.W., Kaps M., et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial. Circulation 111 (2005) 2233-2240
11. Kennedy J., Hill M.D., Ryckborst K.J., Eliasziw M., Demchuk A.M., and Buchan A.M. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 6 (2007) 961-969
12. Chimowitz M.I., Lynn M.J., Howlett-Smith H., et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 352 (2005) 1305-1316
13. Wong K.S., Chen C., Ng P.W., et al. Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study. Lancet Neurol 6 (2007) 407-413
14. Kwon S.U., Cho Y.J., Koo J.S., et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 36 (2005) 782-786
15. King A., and Markus H.S. Doppler embolic signals in cerebrovascular disease and prediction of stroke risk: a systematic review and meta-analysis. Stroke 40 (2009) 3711-3717
16. Markus H.S., and MacKinnon A. Asymptomatic embolization detected by Doppler ultrasound predicts stroke risk in symptomatic carotid artery stenosis. Stroke 36 (2005) 971-975
17. Gao S., Wong K.S., Hansberg T., Lam W.W., Droste D.W., and Ringelstein E.B. Microembolic signal predicts recurrent cerebral ischemic events in acute stroke patients with middle cerebral artery stenosis. Stroke 35 (2004) 2832-2836
18. Wong K.S., Li H., Chan Y.L., et al. Use of transcranial Doppler to predict outcome in patients with intracranial large-artery occlusive disease. Stroke 31 (2000) 2641-2647
19. Wong K.S., Gao S., Chan Y.L., et al. Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol 52 (2002) 74-81
20. Esagunde R.U., Wong K.S., Lee M.P., et al. Efficacy of dual antiplatelet therapy in cerebrovascular disease as demonstrated by a decline in microembolic signals: a report of eight cases. Cerebrovasc Dis 21 (2006) 242-246
21. Ringelstein E.B., Droste D.W., Babikian V.L., et al. Consensus on microembolus detection by TCD. Stroke 29 (1998) 725-729
22. Kaposzta Z., Martin J.F., and Markus H.S. Switching off embolization from symptomatic carotid plaque using S-nitrosoglutathione. Circulation 105 (2002) 1480-1484
23. Kaposzta Z., Baskerville P.A., Madge D., Fraser S., Martin J.F., and Markus H.S. L-arginine and S-nitrosoglutathione reduce embolization in humans. Circulation 103 (2001) 2371-2375
24. Markus H.S., and Molloy J. Use of a decibel threshold in detecting Doppler embolic signals. Stroke 28 (1997) 692-695
25. Kaposzta Z., Clifton A., Molloy J., Martin J.F., and Markus H.S. S-nitrosoglutathione reduces asymptomatic embolization after carotid angioplasty. Circulation 106 (2002) 3057-3062
26. Payne D.A., Jones C.I., Hayes P.D., et al. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation 109 (2004) 1476-1481
27. Wong K.S. Is the measurement of cerebral microembolic signals a good surrogate marker for evaluating the efficacy of antiplatelet agents in the prevention of stroke?. Eur Neurol 53 (2005) 132-139
28. Chung E.M., Fan L., Naylor A.R., and Evans D.H. Impact of clinical environment on embolus detection: a comparison of automated and manual detection of Doppler embolic signals. Cerebrovasc Dis 23 (2007) 169-174
29. Gao S., and Wong K.S. Characteristics of microembolic signals detected near their origins in middle cerebral artery stenoses. J Neuroimaging 13 (2003) 124-132
30. Spence J.D., Coates V., Li H., et al. Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol 67 (2010) 180-186